by Salomi LBSP | May 13, 2025 | News
Azafaros has raised €132 million in an oversubscribed Series B financing round. The funding will support the advancement of its lead clinical-stage asset, AZ-3102, into two Phase 3 trials for the treatment of rare lysosomal storage disorders: GM1 and GM2...
by Salomi LBSP | May 9, 2025 | News
Two Leiden University research teams have been awarded grants through the HTSM programme, supporting advanced technology development with strong industry collaborations. DUAL IMPACT, led by Prof. Joost Batenburg (LIACS), aims to transform quality control in industries...
by Salomi LBSP | May 8, 2025 | News
Researchers at Leiden University Medical Center (LUMC) have developed PERISCOPE, an AI-driven tool designed to predict the risk of infections in postoperative patients. By analyzing nearly a decade of anonymized patient data, including vital signs and medical history,...
by Salomi LBSP | May 6, 2025 | News
NecstGen has partnered with Paris-based biotech Astraveus to evaluate the Lakhesys™ Benchtop Cell Factory™, a microfluidic-based platform aiming to simplify and scale CAR-T production. The collaboration will test the system’s potential to reduce cost, footprint,...
by Bilyana LBSP | May 6, 2025 | News
Leiden Bio Science Park had the honour of hosting a delegation from Trinity College Cambridge, one of the UK’s most prominent investors in science and innovation. Organised in collaboration with CBRE, the visit was part of a broader exploration of what the group...
by Salomi LBSP | May 1, 2025 | News
What if you could design something that acts like an antibody, but cheaper, more stable, and made entirely with chemistry? Two LACDR researchers, Sebastian Pomplun and Matthias Barz, teamed up to do just that. By merging peptide synthesis with polymer chemistry, they...